Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities

Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to evaluate the effectiveness of an adapted, telehealth functional behavioral therapy (FBTsIDD) specifically focused on promoting appropriate communication and behavioral strategies in individuals with syndromic intellectual and developmental disorders. Participants will be asked to complete virtual study assessments at intake and then on a monthly basis for the duration of 3-6 months. In addition, participants will attend weekly or biweekly virtual intervention visits with a study therapist.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 12
Healthy Volunteers: f
View:

• Age(s) 2-12 years old at time of enrollment

• Existing genetic syndrome based on clinical or genetic diagnosis and confirmed by medical records

• Documented diagnosis of global developmental delay (GDD) or intellectual disability (ID)

• estimated ID in all ranges

• Disruptive behavior challenges determined to be clinically appropriate for remote, parent-implemented coaching based on clinician determination of acuity of problem behaviors

• Caregiver who is able to consent in English.

• Parent/caregiver available for weekly intervention sessions

• Stable psychosocial and psychiatric treatments 3 months prior to baseline visit.

Locations
United States
Illinois
Autism Assessment Research Treatment and Services (AARTS) Center at Rush University Medical Center
RECRUITING
Chicago
Contact Information
Primary
Latha Soorya, PhD
Latha_Soorya@rush.edu
312-942-3767
Backup
Allison Wainer, PhD
Allison_Wainer@rush.edu
Time Frame
Start Date: 2023-09-15
Estimated Completion Date: 2026-12
Participants
Target number of participants: 92
Treatments
Experimental: Functional Behavioral Training
Active_comparator: Positive Parenting Strategies-Treatment As Usual
Sponsors
Collaborators: Emory University
Leads: Rush University Medical Center

This content was sourced from clinicaltrials.gov